Garnet Equity Capital Holdings’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Sell
100,746
-11,000
-10% -$285K 0.56% 16
2025
Q4
$2.22M Sell
111,746
-270,216
-71% -$5.2M 0.29% 19
2025
Q3
$6.97M Sell
381,962
-228,581
-37% -$3.76M 2.59% 12
2025
Q2
$9.62M Sell
610,543
-100,000
-14% -$1.27M 2.27% 11
2025
Q1
$9.01M Buy
710,543
+254,954
+56% +$4M 0.91% 10
2024
Q4
$10M Buy
455,589
+92,000
+25% +$1.93M 1.44% 12
2024
Q3
$6.48M Buy
+363,589
New +$5.83M 1.88% 17

Other funds holding CLMT

Garnet Equity Capital Holdings's CLMT Position: Q1 2026 in Review

Garnet Equity Capital Holdings reduced its Calumet Specialty Products (CLMT) stake by 9.8% in Q1 2026, selling an estimated $285K and leaving 100,746 shares worth $3.62M. The position accounts for 0.56% of the portfolio, ranked #16.

Garnet Equity Capital Holdings first reported a position in CLMT in Q3 2024 and has held it in 7 quarters since. The position peaked at $10M in Q4 2024. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Garnet Equity Capital Holdings held 100,746 shares of Calumet Specialty Products worth $3.62M as of Q1 2026.
  • Garnet Equity Capital Holdings sold 11,000 Calumet Specialty Products shares in Q1 2026, an estimated $285K.
  • Calumet Specialty Products made up 0.56% of Garnet Equity Capital Holdings's portfolio in Q1 2026, its #16 holding.
  • Garnet Equity Capital Holdings first reported a position in Calumet Specialty Products in Q3 2024 and has held it in 7 quarters since.
  • Garnet Equity Capital Holdings's Calumet Specialty Products position peaked at $10M in Q4 2024.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Garnet Equity Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.